Uroguanylin (Dolcanatide)
Overview
Uroguanylin is a 16-amino acid endogenous peptide structurally related to guanylin that also activates guanylate cyclase-C receptors in the intestinal epithelium. It regulates fluid and electrolyte secretion in the gut and plays a role in satiety signaling and metabolic homeostasis.
Mechanism of Action
The synthetic analog dolcanatide has been developed to mimic uroguanylin's effects with enhanced stability and bioavailability. Like guanylin, uroguanylin increases cyclic GMP levels, promoting intestinal secretion and motility..
Research Summary & Key Findings
Dolcanatide has been evaluated in clinical trials for chronic constipation and constipation-predominant irritable bowel syndrome, demonstrating improved bowel function in early-phase studies. A phase 2 trial published in 2011 showed dose-dependent increases in bowel movement frequency and stool consistency. Further clinical development has been limited, and the agent has not achieved regulatory approval.
Clinical Status
Uroguanylin (Dolcanatide) is currently undergoing clinical trials. It is not yet FDA-approved and is available only through clinical research settings or investigational protocols.
Administration Routes
Related Peptides in Gastrointestinal
Octreotide (Sandostatin)
FDA ApprovedA synthetic octapeptide analog of somatostatin with a substantially longer half-life (90 minutes IV, 6 hours subcutaneou...
View detailsLanreotide (Somatuline Depot)
FDA ApprovedA synthetic octapeptide analog of somatostatin with high affinity for SSTR2 and moderate affinity for SSTR5 receptors. L...
View detailsPasireotide (Signifor)
FDA ApprovedA multireceptor-targeted somatostatin analog with high binding affinity for SSTR1, SSTR2, SSTR3, and SSTR5, particularly...
View detailsPlecanatide (Trulance)
FDA ApprovedA synthetic 16-amino acid peptide structurally related to uroguanylin, an endogenous intestinal peptide that regulates f...
View detailsFind a Provider
Find a verified provider who offers Uroguanylin (Dolcanatide) therapy in your area.
Browse Provider MapFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Uroguanylin (Dolcanatide).
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.